Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors.

Abstract : Multiple myeloma is a plasma cell cancer with poor survival, characterized by the clonal expansion of multiple myeloma cells (MMC), primarily in the bone marrow. Novel compounds are currently tested in this disease, but partial or minor patients' responses are observed for most compounds used as a single agent. The design of predictors for drug efficacy could be most useful to better understand basic mechanisms targeted by these drugs and design clinical trials. In the current study, we report the building of a DNA methylation score (DM score) predicting the efficacy of decitabine, an inhibitor of DNA methyltransferase (DNMT), targeting methylation-regulated gene expression. DM score was built by identifying 47 genes regulated by decitabine in human myeloma cell lines and the expression of which in primary MMCs of previously untreated patients is predictive for overall survival. A high DM score predicts patients' poor survival, and, of major interest, high sensitivity of primary MMCs or human myeloma cell lines to decitabine in vitro. Thus, DM score could be useful to design novel treatments with DMNT inhibitor in multiple myeloma and has highlighted 47 genes, the gene products of which could be important for multiple myeloma disease development.
Type de document :
Article dans une revue
Molecular Cancer Therapeutics, American Association for Cancer Research, 2012, 11 (12), pp.2685-92. 〈10.1158/1535-7163.MCT-12-0721〉
Liste complète des métadonnées

Littérature citée [43 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00760269
Contributeur : Monique Frei <>
Soumis le : mardi 1 octobre 2013 - 07:00:10
Dernière modification le : vendredi 20 octobre 2017 - 01:17:28
Document(s) archivé(s) le : lundi 6 janvier 2014 - 09:21:43

Fichier

99326_1_merged_1349437964.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Jérôme Moreaux, Thierry Rème, Wim Leonard, Jean-Luc Veyrune, Guilhem Requirand, et al.. Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors.. Molecular Cancer Therapeutics, American Association for Cancer Research, 2012, 11 (12), pp.2685-92. 〈10.1158/1535-7163.MCT-12-0721〉. 〈inserm-00760269〉

Partager

Métriques

Consultations de la notice

265

Téléchargements de fichiers

604